Institutional shares held 95.9 Million
76.4K calls
132K puts
Total value of holdings $803M
$640K calls
$1.11M puts
Market Cap $786M
95,046,400 Shares Out.
Institutional ownership 100.85%
# of Institutions 309


Latest Institutional Activity in TXG

Top Purchases

Q1 2025
Steel Peak Wealth Management LLC Shares Held: 37.1K ($307K)
Q1 2025
Summit Trail Advisors, LLC Shares Held: 36K ($298K)
Q1 2025
Pallas Capital Advisors LLC Shares Held: 23.8K ($197K)
Q1 2025
Diversified Trust CO Shares Held: 57.2K ($473K)
Q1 2025
Teacher Retirement System Of Texas Shares Held: 14.1K ($116K)

Top Sells

Q1 2025
Sumitomo Mitsui Trust Holdings, Inc. Shares Held: 5.36M ($44.4M)
Q1 2025
Assenagon Asset Management S.A. Shares Held: 1.73M ($14.3M)
Q1 2025
Gamma Investing LLC Shares Held: 3.59K ($29.7K)
Q1 2025
Cambridge Investment Research Advisors, Inc. Shares Held: 26.6K ($220K)
Q1 2025
Bank Of New York Mellon Corp Shares Held: 286K ($2.36M)

About TXG

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.


Insider Transactions at TXG

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
814K Shares
From 12 Insiders
Grant, award, or other acquisition 712K shares
Open market or private purchase 40K shares
Exercise of conversion of derivative security 62K shares
Sell / Disposition
59.7K Shares
From 4 Insiders
Open market or private sale 56.1K shares
Bona fide gift 3.63K shares

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if
Any

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG